loadpatents
Patent applications and USPTO patent grants for RUNYON; Scott P..The latest application filed is for "methods and uses for apelin receptor agonists".
Patent | Date |
---|---|
Methods And Uses For Apelin Receptor Agonists App 20220280483 - MAITRA; Rangan ;   et al. | 2022-09-08 |
Apelin receptor (APJ) agonists and uses thereof Grant 11,401,244 - Runyon , et al. August 2, 2 | 2022-08-02 |
Substituted 1,2,3,4-tetrahydroisoquinolines as kappa opioid antagonists Grant 11,292,783 - Carroll , et al. April 5, 2 | 2022-04-05 |
Apelin receptor (APJ) agonists and uses thereof Grant 11,267,789 - Runyon , et al. March 8, 2 | 2022-03-08 |
Apelin receptor (APJ) agonists and uses thereof Grant 10,954,247 - Runyon , et al. March 23, 2 | 2021-03-23 |
Apelin Receptor (apj) Agonists And Uses Thereof App 20210070767 - RUNYON; Scott P. ;   et al. | 2021-03-11 |
Heterocyclic Apelin Receptor (apj) Agonists And Uses Thereof App 20190322644 - RUNYON; Scott P. ;   et al. | 2019-10-24 |
Apelin Receptor (apj) Agonists And Uses Thereof App 20190315693 - RUNYON; Scott P. ;   et al. | 2019-10-17 |
Tetrahydroisoquinoline Kappa Opioid Antagonists App 20190263781 - Carroll; Frank Ivy ;   et al. | 2019-08-29 |
Apelin receptor (APJ) agonists and uses thereof Grant 10,377,718 - Runyon , et al. A | 2019-08-13 |
Apelin receptor (APJ) agonists and uses thereof Grant 10,100,059 - Runyon , et al. October 16, 2 | 2018-10-16 |
Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties Grant 10,087,211 - Runyon , et al. October 2, 2 | 2018-10-02 |
Apelin Receptor (apj) Agonists And Uses Thereof App 20180265518 - RUNYON; Scott P. ;   et al. | 2018-09-20 |
Arylpiperazine opioid receptor antagonists Grant 9,750,738 - Carroll , et al. September 5, 2 | 2017-09-05 |
Apelin Receptor (apj) Agonists And Uses Thereof App 20170166577 - Runyon; Scott P. ;   et al. | 2017-06-15 |
Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties App 20170051008 - RUNYON; Scott P. ;   et al. | 2017-02-23 |
Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties Grant 9,518,080 - Runyon , et al. December 13, 2 | 2016-12-13 |
1-substituted 4-arylpiperazine as kappa opioid receptor antagonists Grant 9,512,105 - Carroll , et al. December 6, 2 | 2016-12-06 |
Apelin Receptor (apj) Agonists And Uses Thereof App 20160207889 - Runyon; Scott P. ;   et al. | 2016-07-21 |
Arylpiperazine Opioid Receptor Antagonists App 20160095854 - CARROLL; Frank I. ;   et al. | 2016-04-07 |
Arylpiperazine opioid receptor antagonists Grant 9,273,027 - Carroll , et al. March 1, 2 | 2016-03-01 |
1-substituted 4-arylpiperazine As Kappa Opioid Receptor Antagonists App 20150005315 - Carroll; Frank I. ;   et al. | 2015-01-01 |
Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties App 20140094619 - RUNYON; Scott P. ;   et al. | 2014-04-03 |
Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties Grant 8,575,375 - Runyon , et al. November 5, 2 | 2013-11-05 |
Arylpiperazine Opioid Receptor Antagonists App 20120295919 - Carroll; Frank I. ;   et al. | 2012-11-22 |
Kappa Opioid Receptor Ligands App 20120178781 - CARROLL; Frank Ivy ;   et al. | 2012-07-12 |
Kappa opioid receptor ligands Grant 8,173,678 - Carroll , et al. May 8, 2 | 2012-05-08 |
Androstane And Pregnane Steroids With Potent Allosteric Gaba Receptor Chloride Ionophore Modulating Properties App 20110092473 - Runyon; Scott P. ;   et al. | 2011-04-21 |
Kappa Opioid Receptor Ligands App 20110065743 - CARROLL; Frank Ivy ;   et al. | 2011-03-17 |
Kappa opioid receptor ligands Grant 7,872,023 - Carroll , et al. January 18, 2 | 2011-01-18 |
Kappa opioid receptor ligands App 20060183743 - Frank; Carroll Ivy ;   et al. | 2006-08-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.